These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16199912)

  • 1. [Calcium antagonists and endothelial function].
    Yasuda O; Kawamoto H; Yokoi T; Rakugi H; Ogihara T
    Clin Calcium; 2005 Oct; 15(10):1663-8. PubMed ID: 16199912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium, atherosclerosis and calcium channel blockers.
    Biswas TK
    J Indian Med Assoc; 2003 Jul; 101(7):428-31. PubMed ID: 14748381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers, endothelial dysfunction, and combination therapy.
    Schulman IH; Zachariah M; Raij L
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endothelial dysfunction in hypertensive subjects.
    Thuillez C; Richard V
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-atherosclerotic action of hypotensive drugs].
    Gmiński J; Stajszczyk M
    Wiad Lek; 1996; 49(7-12):182-98. PubMed ID: 9245114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S34-7. PubMed ID: 11986891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonists: current and future applications based on new evidence. Pleiotropic effects of calcium channel blockers on vascular endothelial function].
    Morimoto Y; Kureishi-Bando Y; Murohara T
    Clin Calcium; 2010 Jan; 20(1):69-75. PubMed ID: 20048436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
    Schiffrin EL
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor.
    Yamasaki K; Aoki M; Makino H; Hashiya N; Shimizu H; Ohishi M; Ogihara T; Morishita R
    J Hum Hypertens; 2004 Oct; 18(10):701-5. PubMed ID: 15071489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
    Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
    Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
    Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
    Neutel JM
    Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists and insulin resistance].
    Higashi Y; Yoshizumi M
    Clin Calcium; 2005 Oct; 15(10):1675-80. PubMed ID: 16199914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics.
    Highlander P; Shaw GP
    Ther Adv Cardiovasc Dis; 2010 Feb; 4(1):43-54. PubMed ID: 19965897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of statins in endothelial dysfunction in hypertension.
    Sarkar K; Sinha AK; Mehta JL
    Curr Opin Cardiol; 2006 Jul; 21(4):316-21. PubMed ID: 16755200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways.
    Fukuo K; Yang J; Yasuda O; Mogi M; Suhara T; Sato N; Suzuki T; Morimoto S; Ogihara T
    Circulation; 2002 Jul; 106(3):356-61. PubMed ID: 12119253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium antagonist and diurnal blood pressure variation].
    Kabutoya T; Kario K
    Clin Calcium; 2005 Oct; 15(10):1631-41. PubMed ID: 16199908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.